6
Participants
Start Date
July 31, 1999
Primary Completion Date
May 31, 2002
Study Completion Date
June 30, 2002
AFP gene hepatocellular carcinoma vaccine
"Patients will receive three biweekly intradermal vaccinations with four HLA-A\*0201-binding AFP-derived peptides emulsified in 2 ml of Montanide ISA-51.~Group A AFP peptide dose 100 ug Group B AFP peptide dose 500 ug Group C AFP peptide dose 1000 ug"
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
National Institutes of Health (NIH)
NIH
Jonsson Comprehensive Cancer Center
OTHER